Welcome to our dedicated page for Simulations Plus SEC filings (Ticker: SLP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
For investors following the niche world of pharmaceutical modeling software, Simulations Plus disclosures are a goldmine—yet finding R&D spending trends or segment revenue inside a dense filing can be daunting. Whether you’re searching for “Simulations Plus quarterly earnings report 10-Q filing” before an update, or need “Simulations Plus proxy statement executive compensation” details to benchmark management incentives, our page brings every document to your screen in seconds.
Stock Titan’s platform pairs real-time EDGAR feeds with AI-powered summaries, so “Simulations Plus SEC filings explained simply” is more than a promise. Our algorithms surface key metrics—software license growth, consulting backlog, new ADMET model releases—and flag “Simulations Plus 8-K material events explained” the moment they post. You can review “Simulations Plus insider trading Form 4 transactions” or set alerts for “Simulations Plus Form 4 insider transactions real-time” to monitor when executives buy or sell shares. Need deeper context? Click once and you’re “understanding Simulations Plus SEC documents with AI” as complicated accounting notes are distilled into plain language.
- “Simulations Plus annual report 10-K simplified” highlights long-term revenue drivers and R&D capitalization choices.
- “Simulations Plus earnings report filing analysis” breaks down quarter-over-quarter operating margin movements.
- “Simulations Plus executive stock transactions Form 4” lists every option exercise alongside historical price graphs.
From the initial S-1 to the latest 10-K, every filing type is archived, searchable, and enriched with expert commentary. Save hours locating segment data, assess insider sentiment before material announcements, and compare performance across years—all in one place.
Form 144 notice for Simulations Plus, Inc. (SLP): An insider proposes to sell 20,000 shares of Common stock through Morgan Stanley Smith Barney on 10/01/2025 with an aggregate market value of $301,400.00. The shares were originally acquired as Founders Shares from the issuer on 07/01/1996. The filing reports 20,127,110 shares outstanding for the class and indicates no securities sold in the past three months by the reporting person. The filer certifies no undisclosed material adverse information and follows the Rule 144 notice format for proposed sale reporting.
Simulations Plus director Lisa LaVange reported the sale of 867 shares of the company's common stock on 09/02/2025. The Form 4 states the shares were sold in a single transaction at $14.10 per share and that the sale was effected automatically pursuant to a Rule 10b5-1 trading plan. Following the reported transaction, Ms. LaVange beneficially owns 9,063 shares and holds those shares in a direct ownership form. The filing indicates the reporter is a director and the Form 4 was executed by an attorney-in-fact on 09/04/2025.
FAQ
What is the current stock price of Simulations Plus (SLP)?
What is the market cap of Simulations Plus (SLP)?
